Skip to content
Urban Bridge Plus

The Zimbabwean Government Turns Down ‘One-Sided’ American Healthcare Assistance Agreement Because of Data Concerns

Medical funding illustration
The offered US funding was intended for initiatives for treating and preventing HIV/Aids, TB, and malarial diseases.

The nation of Zimbabwe has turned down a major US healthcare agreement valued at $367m (272 million pounds) spanning five years because of the United States' insistence on sensitive data.

The decision came to light after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

An official representative later stated that the United States was requesting biological samples for research and profit but was unwilling to share the resulting advantages from future medical innovations.

"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for more negotiations to find a deal suitable to all parties so the nation's critical HIV treatment initiative can be sustained.

Broader Implications

This rejection comes after a comparable case in Kenya, where a court suspended a related health funding agreement after concerns were filed about the safety of citizens' health data.

After returning to the presidency last year, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had overseen aid for the US government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to boost openness and accountability.

As per statements, 16 African countries have so far agreed to similar health pacts, representing over $18.3bn in new funding.

Details of the Rejected Agreement

The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"It is our view this partnership would have delivered immense benefits for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via American-funded initiatives," Tremont said.

However, government spokesperson Nick Mangwana said the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no equivalent guarantee of access to any scientific breakthroughs – like new medicines or tests – that might be developed from that shared data," his statement read.

"Effectively, our country would provide the raw materials for scientific discovery with no assurance that the end products would be available to our people if a future health crisis emerge."

National Interest and Global Health

He also pointed out that the American exit from the World Health Organization (WHO) and its pursuit of bilateral deals were upending structures previously set up via the international organization.

Mangwana cited its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.

"This framework is intended to guarantee that when a country contributes its data, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."

Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.

"We welcome continued discussions with our US partners on how future collaboration could be designed in a way that honours the independence and interests of both nations."

Medical Community Reaction

Medical experts said it recognised the government's concerns, but urged that talks should continue given that a large portion of the country's Aids initiatives were funded by international support.

"In cases where technical issues exist, such as those relating to data governance or agreement terms, these can often be addressed via detailed discussion and mutually agreed protections," the group said.

This impasse emphasises the ongoing debate between accepting vital international aid and safeguarding a country's data in an increasingly interconnected world.

About the author

Ellen Adams

Elena Voss is an urban planner and writer, passionate about sustainable cities and community-driven design.

Urban Bridge Plus

Type to search articles.